ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gliclazide Sustained-release Tablet Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-5B14160
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Gliclazide Sustained release Tablet Market Research Report 2023
BUY CHAPTERS

Global Gliclazide Sustained-release Tablet Market Research Report 2025

Code: QYRE-Auto-5B14160
Report
May 2025
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Servier Laboratories
Torrent Pharmaceuticals
Aurobindo Pharma
TEVA
Zydus Cadila Healthcare
Sanofi
Mylan Pharmaceuticals
Accord Healthcare
Yiling Pharmaceutical
Lukang Jituan Saite Yaoye
Shijiazhuang SIYAO

Gliclazide Sustained-release Tablet Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Gliclazide Sustained-release Tablet Market

Gliclazide Sustained-release Tablet Market

The global market for Gliclazide Sustained-release Tablet was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Gliclazide is an oral antidiabetic medication used to treat type 2 diabetes mellitus. It belongs to the class of sulfonylurea drugs, which work by stimulating the pancreas to produce more insulin and increasing the body"s sensitivity to insulin. Gliclazide sustained-release tablets, often referred to as extended-release or controlled-release tablets, are a specific formulation of this medication.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gliclazide Sustained-release Tablet, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gliclazide Sustained-release Tablet.
The Gliclazide Sustained-release Tablet market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gliclazide Sustained-release Tablet market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gliclazide Sustained-release Tablet manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Gliclazide Sustained-release Tablet Market Report

Report Metric Details
Report Name Gliclazide Sustained-release Tablet Market
CAGR 5%
Segment by Type
  • 30mg
  • 60mg
  • Other
Segment by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Servier Laboratories, Torrent Pharmaceuticals, Aurobindo Pharma, Teva, Zydus Cadila Healthcare, Sanofi S.A., Mylan Pharmaceuticals, Accord Healthcare, Lukang Jituan Saite Yaoye, Shijiazhuang SIYAO, Yiling Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Gliclazide Sustained-release Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Gliclazide Sustained-release Tablet in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Gliclazide Sustained-release Tablet Market report?

Ans: The main players in the Gliclazide Sustained-release Tablet Market are Servier Laboratories, Torrent Pharmaceuticals, Aurobindo Pharma, Teva, Zydus Cadila Healthcare, Sanofi S.A., Mylan Pharmaceuticals, Accord Healthcare, Lukang Jituan Saite Yaoye, Shijiazhuang SIYAO, Yiling Pharmaceutical

What are the Application segmentation covered in the Gliclazide Sustained-release Tablet Market report?

Ans: The Applications covered in the Gliclazide Sustained-release Tablet Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Gliclazide Sustained-release Tablet Market report?

Ans: The Types covered in the Gliclazide Sustained-release Tablet Market report are 30mg, 60mg, Other

Recommended Reports

Diabetes Drug Markets

Oral & Sustained Tablets

Chronic Disease Treatments

1 Gliclazide Sustained-release Tablet Market Overview
1.1 Product Definition
1.2 Gliclazide Sustained-release Tablet by Type
1.2.1 Global Gliclazide Sustained-release Tablet Market Value Comparison by Type (2024 VS 2031)
1.2.2 30mg
1.2.3 60mg
1.2.4 Other
1.3 Gliclazide Sustained-release Tablet by Application
1.3.1 Global Gliclazide Sustained-release Tablet Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Gliclazide Sustained-release Tablet Market Size Estimates and Forecasts
1.4.1 Global Gliclazide Sustained-release Tablet Revenue 2020-2031
1.4.2 Global Gliclazide Sustained-release Tablet Sales 2020-2031
1.4.3 Global Gliclazide Sustained-release Tablet Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Gliclazide Sustained-release Tablet Market Competition by Manufacturers
2.1 Global Gliclazide Sustained-release Tablet Sales Market Share by Manufacturers (2020-2025)
2.2 Global Gliclazide Sustained-release Tablet Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Gliclazide Sustained-release Tablet Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Gliclazide Sustained-release Tablet, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gliclazide Sustained-release Tablet, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gliclazide Sustained-release Tablet, Product Type & Application
2.7 Global Key Manufacturers of Gliclazide Sustained-release Tablet, Date of Enter into This Industry
2.8 Global Gliclazide Sustained-release Tablet Market Competitive Situation and Trends
2.8.1 Global Gliclazide Sustained-release Tablet Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Gliclazide Sustained-release Tablet Players Market Share by Revenue
2.8.3 Global Gliclazide Sustained-release Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Gliclazide Sustained-release Tablet Market Scenario by Region
3.1 Global Gliclazide Sustained-release Tablet Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Gliclazide Sustained-release Tablet Sales by Region: 2020-2031
3.2.1 Global Gliclazide Sustained-release Tablet Sales by Region: 2020-2025
3.2.2 Global Gliclazide Sustained-release Tablet Sales by Region: 2026-2031
3.3 Global Gliclazide Sustained-release Tablet Revenue by Region: 2020-2031
3.3.1 Global Gliclazide Sustained-release Tablet Revenue by Region: 2020-2025
3.3.2 Global Gliclazide Sustained-release Tablet Revenue by Region: 2026-2031
3.4 North America Gliclazide Sustained-release Tablet Market Facts & Figures by Country
3.4.1 North America Gliclazide Sustained-release Tablet Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Gliclazide Sustained-release Tablet Sales by Country (2020-2031)
3.4.3 North America Gliclazide Sustained-release Tablet Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Gliclazide Sustained-release Tablet Market Facts & Figures by Country
3.5.1 Europe Gliclazide Sustained-release Tablet Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Gliclazide Sustained-release Tablet Sales by Country (2020-2031)
3.5.3 Europe Gliclazide Sustained-release Tablet Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gliclazide Sustained-release Tablet Market Facts & Figures by Region
3.6.1 Asia Pacific Gliclazide Sustained-release Tablet Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Gliclazide Sustained-release Tablet Sales by Region (2020-2031)
3.6.3 Asia Pacific Gliclazide Sustained-release Tablet Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Gliclazide Sustained-release Tablet Market Facts & Figures by Country
3.7.1 Latin America Gliclazide Sustained-release Tablet Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Gliclazide Sustained-release Tablet Sales by Country (2020-2031)
3.7.3 Latin America Gliclazide Sustained-release Tablet Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gliclazide Sustained-release Tablet Market Facts & Figures by Country
3.8.1 Middle East and Africa Gliclazide Sustained-release Tablet Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Gliclazide Sustained-release Tablet Sales by Country (2020-2031)
3.8.3 Middle East and Africa Gliclazide Sustained-release Tablet Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gliclazide Sustained-release Tablet Sales by Type (2020-2031)
4.1.1 Global Gliclazide Sustained-release Tablet Sales by Type (2020-2025)
4.1.2 Global Gliclazide Sustained-release Tablet Sales by Type (2026-2031)
4.1.3 Global Gliclazide Sustained-release Tablet Sales Market Share by Type (2020-2031)
4.2 Global Gliclazide Sustained-release Tablet Revenue by Type (2020-2031)
4.2.1 Global Gliclazide Sustained-release Tablet Revenue by Type (2020-2025)
4.2.2 Global Gliclazide Sustained-release Tablet Revenue by Type (2026-2031)
4.2.3 Global Gliclazide Sustained-release Tablet Revenue Market Share by Type (2020-2031)
4.3 Global Gliclazide Sustained-release Tablet Price by Type (2020-2031)
5 Segment by Application
5.1 Global Gliclazide Sustained-release Tablet Sales by Application (2020-2031)
5.1.1 Global Gliclazide Sustained-release Tablet Sales by Application (2020-2025)
5.1.2 Global Gliclazide Sustained-release Tablet Sales by Application (2026-2031)
5.1.3 Global Gliclazide Sustained-release Tablet Sales Market Share by Application (2020-2031)
5.2 Global Gliclazide Sustained-release Tablet Revenue by Application (2020-2031)
5.2.1 Global Gliclazide Sustained-release Tablet Revenue by Application (2020-2025)
5.2.2 Global Gliclazide Sustained-release Tablet Revenue by Application (2026-2031)
5.2.3 Global Gliclazide Sustained-release Tablet Revenue Market Share by Application (2020-2031)
5.3 Global Gliclazide Sustained-release Tablet Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Servier Laboratories
6.1.1 Servier Laboratories Company Information
6.1.2 Servier Laboratories Description and Business Overview
6.1.3 Servier Laboratories Gliclazide Sustained-release Tablet Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Servier Laboratories Gliclazide Sustained-release Tablet Product Portfolio
6.1.5 Servier Laboratories Recent Developments/Updates
6.2 Torrent Pharmaceuticals
6.2.1 Torrent Pharmaceuticals Company Information
6.2.2 Torrent Pharmaceuticals Description and Business Overview
6.2.3 Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Product Portfolio
6.2.5 Torrent Pharmaceuticals Recent Developments/Updates
6.3 Aurobindo Pharma
6.3.1 Aurobindo Pharma Company Information
6.3.2 Aurobindo Pharma Description and Business Overview
6.3.3 Aurobindo Pharma Gliclazide Sustained-release Tablet Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Aurobindo Pharma Gliclazide Sustained-release Tablet Product Portfolio
6.3.5 Aurobindo Pharma Recent Developments/Updates
6.4 Teva
6.4.1 Teva Company Information
6.4.2 Teva Description and Business Overview
6.4.3 Teva Gliclazide Sustained-release Tablet Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Teva Gliclazide Sustained-release Tablet Product Portfolio
6.4.5 Teva Recent Developments/Updates
6.5 Zydus Cadila Healthcare
6.5.1 Zydus Cadila Healthcare Company Information
6.5.2 Zydus Cadila Healthcare Description and Business Overview
6.5.3 Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Product Portfolio
6.5.5 Zydus Cadila Healthcare Recent Developments/Updates
6.6 Sanofi S.A.
6.6.1 Sanofi S.A. Company Information
6.6.2 Sanofi S.A. Description and Business Overview
6.6.3 Sanofi S.A. Gliclazide Sustained-release Tablet Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sanofi S.A. Gliclazide Sustained-release Tablet Product Portfolio
6.6.5 Sanofi S.A. Recent Developments/Updates
6.7 Mylan Pharmaceuticals
6.7.1 Mylan Pharmaceuticals Company Information
6.7.2 Mylan Pharmaceuticals Description and Business Overview
6.7.3 Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Product Portfolio
6.7.5 Mylan Pharmaceuticals Recent Developments/Updates
6.8 Accord Healthcare
6.8.1 Accord Healthcare Company Information
6.8.2 Accord Healthcare Description and Business Overview
6.8.3 Accord Healthcare Gliclazide Sustained-release Tablet Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Accord Healthcare Gliclazide Sustained-release Tablet Product Portfolio
6.8.5 Accord Healthcare Recent Developments/Updates
6.9 Lukang Jituan Saite Yaoye
6.9.1 Lukang Jituan Saite Yaoye Company Information
6.9.2 Lukang Jituan Saite Yaoye Description and Business Overview
6.9.3 Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Product Portfolio
6.9.5 Lukang Jituan Saite Yaoye Recent Developments/Updates
6.10 Shijiazhuang SIYAO
6.10.1 Shijiazhuang SIYAO Company Information
6.10.2 Shijiazhuang SIYAO Description and Business Overview
6.10.3 Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Product Portfolio
6.10.5 Shijiazhuang SIYAO Recent Developments/Updates
6.11 Yiling Pharmaceutical
6.11.1 Yiling Pharmaceutical Company Information
6.11.2 Yiling Pharmaceutical Description and Business Overview
6.11.3 Yiling Pharmaceutical Gliclazide Sustained-release Tablet Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Yiling Pharmaceutical Gliclazide Sustained-release Tablet Product Portfolio
6.11.5 Yiling Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gliclazide Sustained-release Tablet Industry Chain Analysis
7.2 Gliclazide Sustained-release Tablet Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gliclazide Sustained-release Tablet Production Mode & Process Analysis
7.4 Gliclazide Sustained-release Tablet Sales and Marketing
7.4.1 Gliclazide Sustained-release Tablet Sales Channels
7.4.2 Gliclazide Sustained-release Tablet Distributors
7.5 Gliclazide Sustained-release Tablet Customer Analysis
8 Gliclazide Sustained-release Tablet Market Dynamics
8.1 Gliclazide Sustained-release Tablet Industry Trends
8.2 Gliclazide Sustained-release Tablet Market Drivers
8.3 Gliclazide Sustained-release Tablet Market Challenges
8.4 Gliclazide Sustained-release Tablet Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Servier Laboratories
Torrent Pharmaceuticals
Aurobindo Pharma
TEVA
Zydus Cadila Healthcare
Sanofi
Mylan Pharmaceuticals
Accord Healthcare
Yiling Pharmaceutical
Lukang Jituan Saite Yaoye
Shijiazhuang SIYAO
List of Tables
 Table 1. Global Gliclazide Sustained-release Tablet Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Gliclazide Sustained-release Tablet Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Gliclazide Sustained-release Tablet Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Gliclazide Sustained-release Tablet Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Gliclazide Sustained-release Tablet Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Gliclazide Sustained-release Tablet Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Gliclazide Sustained-release Tablet Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Gliclazide Sustained-release Tablet Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Gliclazide Sustained-release Tablet, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Gliclazide Sustained-release Tablet, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Gliclazide Sustained-release Tablet, Product Type & Application
 Table 12. Global Key Manufacturers of Gliclazide Sustained-release Tablet, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Gliclazide Sustained-release Tablet by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gliclazide Sustained-release Tablet as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Gliclazide Sustained-release Tablet Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Gliclazide Sustained-release Tablet Sales by Region (2020-2025) & (K Units)
 Table 18. Global Gliclazide Sustained-release Tablet Sales Market Share by Region (2020-2025)
 Table 19. Global Gliclazide Sustained-release Tablet Sales by Region (2026-2031) & (K Units)
 Table 20. Global Gliclazide Sustained-release Tablet Sales Market Share by Region (2026-2031)
 Table 21. Global Gliclazide Sustained-release Tablet Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Gliclazide Sustained-release Tablet Revenue Market Share by Region (2020-2025)
 Table 23. Global Gliclazide Sustained-release Tablet Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Gliclazide Sustained-release Tablet Revenue Market Share by Region (2026-2031)
 Table 25. North America Gliclazide Sustained-release Tablet Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Gliclazide Sustained-release Tablet Sales by Country (2020-2025) & (K Units)
 Table 27. North America Gliclazide Sustained-release Tablet Sales by Country (2026-2031) & (K Units)
 Table 28. North America Gliclazide Sustained-release Tablet Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Gliclazide Sustained-release Tablet Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Gliclazide Sustained-release Tablet Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Gliclazide Sustained-release Tablet Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Gliclazide Sustained-release Tablet Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Gliclazide Sustained-release Tablet Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Gliclazide Sustained-release Tablet Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Gliclazide Sustained-release Tablet Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Gliclazide Sustained-release Tablet Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Gliclazide Sustained-release Tablet Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Gliclazide Sustained-release Tablet Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Gliclazide Sustained-release Tablet Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Gliclazide Sustained-release Tablet Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Gliclazide Sustained-release Tablet Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Gliclazide Sustained-release Tablet Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Gliclazide Sustained-release Tablet Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Gliclazide Sustained-release Tablet Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Gliclazide Sustained-release Tablet Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Gliclazide Sustained-release Tablet Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Gliclazide Sustained-release Tablet Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Gliclazide Sustained-release Tablet Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Gliclazide Sustained-release Tablet Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Gliclazide Sustained-release Tablet Sales (K Units) by Type (2020-2025)
 Table 51. Global Gliclazide Sustained-release Tablet Sales (K Units) by Type (2026-2031)
 Table 52. Global Gliclazide Sustained-release Tablet Sales Market Share by Type (2020-2025)
 Table 53. Global Gliclazide Sustained-release Tablet Sales Market Share by Type (2026-2031)
 Table 54. Global Gliclazide Sustained-release Tablet Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Gliclazide Sustained-release Tablet Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Gliclazide Sustained-release Tablet Revenue Market Share by Type (2020-2025)
 Table 57. Global Gliclazide Sustained-release Tablet Revenue Market Share by Type (2026-2031)
 Table 58. Global Gliclazide Sustained-release Tablet Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Gliclazide Sustained-release Tablet Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Gliclazide Sustained-release Tablet Sales (K Units) by Application (2020-2025)
 Table 61. Global Gliclazide Sustained-release Tablet Sales (K Units) by Application (2026-2031)
 Table 62. Global Gliclazide Sustained-release Tablet Sales Market Share by Application (2020-2025)
 Table 63. Global Gliclazide Sustained-release Tablet Sales Market Share by Application (2026-2031)
 Table 64. Global Gliclazide Sustained-release Tablet Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Gliclazide Sustained-release Tablet Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Gliclazide Sustained-release Tablet Revenue Market Share by Application (2020-2025)
 Table 67. Global Gliclazide Sustained-release Tablet Revenue Market Share by Application (2026-2031)
 Table 68. Global Gliclazide Sustained-release Tablet Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Gliclazide Sustained-release Tablet Price (US$/Unit) by Application (2026-2031)
 Table 70. Servier Laboratories Company Information
 Table 71. Servier Laboratories Description and Business Overview
 Table 72. Servier Laboratories Gliclazide Sustained-release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Servier Laboratories Gliclazide Sustained-release Tablet Product
 Table 74. Servier Laboratories Recent Developments/Updates
 Table 75. Torrent Pharmaceuticals Company Information
 Table 76. Torrent Pharmaceuticals Description and Business Overview
 Table 77. Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Product
 Table 79. Torrent Pharmaceuticals Recent Developments/Updates
 Table 80. Aurobindo Pharma Company Information
 Table 81. Aurobindo Pharma Description and Business Overview
 Table 82. Aurobindo Pharma Gliclazide Sustained-release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Aurobindo Pharma Gliclazide Sustained-release Tablet Product
 Table 84. Aurobindo Pharma Recent Developments/Updates
 Table 85. Teva Company Information
 Table 86. Teva Description and Business Overview
 Table 87. Teva Gliclazide Sustained-release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Teva Gliclazide Sustained-release Tablet Product
 Table 89. Teva Recent Developments/Updates
 Table 90. Zydus Cadila Healthcare Company Information
 Table 91. Zydus Cadila Healthcare Description and Business Overview
 Table 92. Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Product
 Table 94. Zydus Cadila Healthcare Recent Developments/Updates
 Table 95. Sanofi S.A. Company Information
 Table 96. Sanofi S.A. Description and Business Overview
 Table 97. Sanofi S.A. Gliclazide Sustained-release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Sanofi S.A. Gliclazide Sustained-release Tablet Product
 Table 99. Sanofi S.A. Recent Developments/Updates
 Table 100. Mylan Pharmaceuticals Company Information
 Table 101. Mylan Pharmaceuticals Description and Business Overview
 Table 102. Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Product
 Table 104. Mylan Pharmaceuticals Recent Developments/Updates
 Table 105. Accord Healthcare Company Information
 Table 106. Accord Healthcare Description and Business Overview
 Table 107. Accord Healthcare Gliclazide Sustained-release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Accord Healthcare Gliclazide Sustained-release Tablet Product
 Table 109. Accord Healthcare Recent Developments/Updates
 Table 110. Lukang Jituan Saite Yaoye Company Information
 Table 111. Lukang Jituan Saite Yaoye Description and Business Overview
 Table 112. Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Product
 Table 114. Lukang Jituan Saite Yaoye Recent Developments/Updates
 Table 115. Shijiazhuang SIYAO Company Information
 Table 116. Shijiazhuang SIYAO Description and Business Overview
 Table 117. Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Product
 Table 119. Shijiazhuang SIYAO Recent Developments/Updates
 Table 120. Yiling Pharmaceutical Company Information
 Table 121. Yiling Pharmaceutical Description and Business Overview
 Table 122. Yiling Pharmaceutical Gliclazide Sustained-release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Yiling Pharmaceutical Gliclazide Sustained-release Tablet Product
 Table 124. Yiling Pharmaceutical Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Gliclazide Sustained-release Tablet Distributors List
 Table 128. Gliclazide Sustained-release Tablet Customers List
 Table 129. Gliclazide Sustained-release Tablet Market Trends
 Table 130. Gliclazide Sustained-release Tablet Market Drivers
 Table 131. Gliclazide Sustained-release Tablet Market Challenges
 Table 132. Gliclazide Sustained-release Tablet Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Gliclazide Sustained-release Tablet
 Figure 2. Global Gliclazide Sustained-release Tablet Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Gliclazide Sustained-release Tablet Market Share by Type: 2024 & 2031
 Figure 4. 30mg Product Picture
 Figure 5. 60mg Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Gliclazide Sustained-release Tablet Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Gliclazide Sustained-release Tablet Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Clinic
 Figure 11. Other
 Figure 12. Global Gliclazide Sustained-release Tablet Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Gliclazide Sustained-release Tablet Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Gliclazide Sustained-release Tablet Sales (2020-2031) & (K Units)
 Figure 15. Global Gliclazide Sustained-release Tablet Average Price (US$/Unit) & (2020-2031)
 Figure 16. Gliclazide Sustained-release Tablet Report Years Considered
 Figure 17. Gliclazide Sustained-release Tablet Sales Share by Manufacturers in 2024
 Figure 18. Global Gliclazide Sustained-release Tablet Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Gliclazide Sustained-release Tablet Players: Market Share by Revenue in Gliclazide Sustained-release Tablet in 2024
 Figure 20. Gliclazide Sustained-release Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Gliclazide Sustained-release Tablet Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Gliclazide Sustained-release Tablet Sales Market Share by Country (2020-2031)
 Figure 23. North America Gliclazide Sustained-release Tablet Revenue Market Share by Country (2020-2031)
 Figure 24. United States Gliclazide Sustained-release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Gliclazide Sustained-release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Gliclazide Sustained-release Tablet Sales Market Share by Country (2020-2031)
 Figure 27. Europe Gliclazide Sustained-release Tablet Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Gliclazide Sustained-release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Gliclazide Sustained-release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Gliclazide Sustained-release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Gliclazide Sustained-release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Gliclazide Sustained-release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Gliclazide Sustained-release Tablet Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Gliclazide Sustained-release Tablet Revenue Market Share by Region (2020-2031)
 Figure 35. China Gliclazide Sustained-release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Gliclazide Sustained-release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Gliclazide Sustained-release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Gliclazide Sustained-release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Gliclazide Sustained-release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Gliclazide Sustained-release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Gliclazide Sustained-release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Gliclazide Sustained-release Tablet Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Gliclazide Sustained-release Tablet Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Gliclazide Sustained-release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Gliclazide Sustained-release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Gliclazide Sustained-release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Gliclazide Sustained-release Tablet Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Gliclazide Sustained-release Tablet Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Gliclazide Sustained-release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Gliclazide Sustained-release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Gliclazide Sustained-release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Gliclazide Sustained-release Tablet by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Gliclazide Sustained-release Tablet by Type (2020-2031)
 Figure 54. Global Gliclazide Sustained-release Tablet Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Gliclazide Sustained-release Tablet by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Gliclazide Sustained-release Tablet by Application (2020-2031)
 Figure 57. Global Gliclazide Sustained-release Tablet Price (US$/Unit) by Application (2020-2031)
 Figure 58. Gliclazide Sustained-release Tablet Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Gliclazide API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gliclazide Market Research Report 2024
Metformin Hydrochloride Sustained release Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Sustained and Controlled Release Formulations Market Research Report 2025
Global Metformin Hydrochloride Sustained release Tablets Market Research Report 2024
Isosorbide Mononitrate Sustained release Tablet Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gliclazide Reagent Market Research Report 2024
Global Sustained and Controlled Release Formulations Market Research Report 2025
Theophylline Sustained Release Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cefaclor Sustained Release Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Controlled Release Drug Delivery Technology Market Research Report 2024
Oral Hypoglycemic Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Sustained Release Film Coating Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Glimepiride Tablet Market Research Report 2024
Tamsulosin Hydrochloride Sustained Release Capsules Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Diclofenac Sodium Sustained release Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Doxazosin Mesylate Extended Release Tablets Market Research Report 2024
Glycemic Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antidiabetic Sulphonylureas Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oral Hypoglycemic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions